By The Legal Intelligencer | April 9, 2019
In The Legal's Medical Malpractice supplement, read about how not being entirely truthful to your doctor can affect your case, the debate over whether to cut the state's venue rule and the complex landscape of EHR and medical malpractice litigation.
The Legal Intelligencer | Commentary
By T. Kevin Fitzpatrick and Rachel C. Bekerman | April 6, 2019
In a move that shocked health care practitioners and facilities throughout the state, the Pennsylvania Supreme Court Civil Procedural Rules Committee…
The Legal Intelligencer | Commentary
By Kim Kocher and Daniel J. Ferhat | April 5, 2019
The Civil Procedural Rules Committee's proposed rescission of the venue rule in medical malpractice cases has sparked spirited debate in legislative, medical, legal and underwriting spheres.
The Legal Intelligencer | Commentary
By Sophia G. Tyris | April 4, 2019
Accuracy and honesty are critical to the patient-doctor relationship, yet studies show that up to 38 percent of patients concealed significant facts when undergoing medical treatment.
The Legal Intelligencer | Commentary
By Nicholas Sandercock | April 4, 2019
Electronic health records (EHR) are as common in the modern health care landscape as needles and syringes. This is thanks in large part to the Health Information Technology for Economic and Clinical Health Act (HITECH), created in 2009.
By The Legal Intelligencer | April 2, 2019
In The Legal's Intellectual Property supplement, read about how government shutdowns affect IP rights, patent litigation in the cannabis industry and infringement issues in artificial intelligence patents.
The Legal Intelligencer | Commentary
By Ameya V. Paradkar and Ji Young Park | March 29, 2019
Artificial intelligence (AI), also referred to as machine-learning technology, refers to software that applies data to incrementally improve its functionality and output.
The Legal Intelligencer | Commentary
By Matthew A. Pearson, Angie Verrecchio and Jason Weil | March 29, 2019
For pharmaceutical inventions, which usually undergo a lengthy FDA approval process before any drug can be sold, the most valuable portion of patent term is at the end of the patent's life, after FDA approval.
The Legal Intelligencer | Commentary
By Chipo M. Jolibois and Shahnam Sharareh | March 28, 2019
In this article, we briefly review the doctrine of inherency, in the context of an obviousness rejection, as a bar to patentability.
The Legal Intelligencer | Commentary
By James Gould | March 28, 2019
Thanks to recent decisions by the U.S. Court of Appeals for the Federal Circuit (CAFC), we have clarity that both requirements must be met to appeal an adverse final written decision issued during that IPR, and we also have some guidance as to how these requirements will be determined in such cases.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
Consulting Magazine identifies consultants that have the biggest impact on their clients, firms and the profession.
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Company Description CourtLaw Injury Lawyers is an established Personal Injury Law Firm with its primary office located in Perth Amboy, New J...
Black Owl Recruiting is looking for a number of qualified applicants to fill positions for a highly reputable client. Recent experience work...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS